(2S)-6-iodo-3,4-dihydro-2H-chromene-2-carboxylic acid | 474111-17-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡喃
• 英文名称: (2S)-6-iodo-3,4-dihydro-2H-chromene-2-carboxylic acid
• CAS: 474111-17-6
• 化学式: C₁₀H₉IO₃
• 分子量: 304.084
• InChiKey: KUUOJGIUGRFQCR-VIFPVBQESA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (2S)-6-iodo-3,4-dihydro-2H-chromene-2-carboxylic acid 在 palladium on activated charcoal 盐酸 、 lithium hydroxide 、 氢气 、 O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate 、 三乙胺 作用下， 以 四氢呋喃 、 甲醇 、 二氯甲烷 为溶剂， 生成 (2-{[2-({S}-3-hydroxy-pyrrolidin-1-yl)-{S}-1-phenyl-ethyl]-(S)-methyl-carbamoyl}-chroman-6-ylmethyl)-carbamic acid methyl ester
  参考文献：
  名称：

  Potent and highly selective kappa opioid receptor agonists incorporating chroman- and 2,3-dihydrobenzofuran-based constraints

  摘要：

  Two novel chemical classes of kappa opioid receptor agonists, chroman-2-carboxamide derivatives and 2,3-dihydrobenzofuran-2-carboxamide derivatives, were synthesized. These agents exhibited high and selective affinity for the kappa opioid receptor. (c) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2005.08.094
• 作为产物：
  描述：

  苯并二氢吡喃-2-羧酸 在 N,N,N-trimethylbenzenemethanaminium dichloroiodate 、 溶剂黄146 、 zinc(II) chloride 作用下， 生成 (2S)-6-iodo-3,4-dihydro-2H-chromene-2-carboxylic acid
  参考文献：
  名称：

  Potent and highly selective kappa opioid receptor agonists incorporating chroman- and 2,3-dihydrobenzofuran-based constraints

  摘要：

  Two novel chemical classes of kappa opioid receptor agonists, chroman-2-carboxamide derivatives and 2,3-dihydrobenzofuran-2-carboxamide derivatives, were synthesized. These agents exhibited high and selective affinity for the kappa opioid receptor. (c) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2005.08.094

文献信息

• Fused bicyclic carboxamide derivatives and methods of their use
  申请人：Dolle E. Roland

  公开号：US20050054630A1

  公开（公告）日：2005-03-10

  Fused bicyclic carboxamide derivatives are disclosed. Pharmaceutical compositions containing the compounds and methods for their use are also disclosed.

  揭示了融合的双环羧酰胺衍生物。还公开了含有这些化合物的药物组合物以及它们的使用方法。
• 2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
  申请人：——

  公开号：US20030078260A1

  公开（公告）日：2003-04-24

  This invention relates to novel 2,6-substituted chroman derivatives which are useful in the treatment of beta-3 adrenoreceptor-mediated conditions.

  这项发明涉及新颖的2,6-取代的色苷衍生物，可用于治疗β-3肾上腺素受体介导的疾病。
• Synthesis of optically active 6-substituted 2-(aminomethyl)chromans
  作者：Mingbao Zhang、Raymond Reeves、Cheng Bi、Robert Dally、Gaetan Ladouceur、William Bullock、Jefferson Chin

  DOI：10.1016/j.tetlet.2004.05.037

  日期：2004.6

  Three novel, optically active, 6-substituted 2-(aminomethyl)chromans were synthesized from readily available chroman 2-carboxylic acid precursors. These chroman-containing primary amines are useful building blocks for the synthesis of chroman-derived pharmaceutical agents.

  从容易获得的苯并二氢吡喃2-羧酸前体合成了三种新型的旋光的6-取代的2-（氨基甲基）苯并吡喃。这些含苯并二氢吡喃的伯胺是合成苯并二氢吡喃衍生物的有用试剂。
• 2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
  申请人：O'Connor Stephen J.

  公开号：US06919371B2

  公开（公告）日：2005-07-19

  This invention relates to novel 2,6-substituted chroman derivatives which are useful in the treatment of beta-3 adrenoreceptor-mediated conditions.

  本发明涉及一种新型的2,6-取代的色甘醇衍生物，可用于治疗β-3肾上腺素能受体介导的疾病。
• 2,6-SUBSTITUTED CHROMAN DERIVATIVES USEFUL AS BETA-3 ADRENORECEPTOR AGONISTS
  申请人：Bayer Pharmaceuticals Corporation

  公开号：EP1389202A1

  公开（公告）日：2004-02-18